Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00690560 |
|
Recruitment Status
:
Completed
First Posted
: June 4, 2008
Last Update Posted
: February 10, 2015
|
Sponsor:
Centre Antoine Lacassagne
Information provided by (Responsible Party):
Centre Antoine Lacassagne
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | March 2010 |
| Actual Study Completion Date : | October 2010 |